- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Peripheral Arterial Disease (PAD) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Peripheral Arterial Disease (PAD) Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Peripheral Arterial Disease (PAD) Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Clopidogrel (Plavix) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Peripheral Arterial Disease (PAD) Drugs include AstraZeneca (UK), Bayer HealthCare Pharmaceuticals (Germany), Bristol-Myers Squibb Company (US), Merck & Co (US), and Proteon Therapeutics (US), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peripheral Arterial Disease (PAD) Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
AstraZeneca (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co (US)
Proteon Therapeutics (US)
Sanofi (France)
Symic Bio (US)
TheraVasc (US)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Peripheral Arterial Disease (PAD) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Peripheral Arterial Disease (PAD) Drugs, with revenue, gross margin and global market share of Peripheral Arterial Disease (PAD) Drugs from 2019 to 2022.
Chapter 3, the Peripheral Arterial Disease (PAD) Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Peripheral Arterial Disease (PAD) Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Peripheral Arterial Disease (PAD) Drugs research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Peripheral Arterial Disease (PAD) Drugs
1.2 Classification of Peripheral Arterial Disease (PAD) Drugs by Type
1.2.1 Overview: Global Peripheral Arterial Disease (PAD) Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type in 2021
1.2.3 Clopidogrel (Plavix)
1.2.4 Prasugrel (Effient)
1.2.5 Ticagrelor (Brilinta)
1.2.6 Vorapaxar (Zontivity)
1.2.7 Others
1.3 Global Peripheral Arterial Disease (PAD) Drugs Market by Application
1.3.1 Overview: Global Peripheral Arterial Disease (PAD) Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Peripheral Arterial Disease (PAD) Drugs Market Size & Forecast
1.5 Global Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast by Region
1.5.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Peripheral Arterial Disease (PAD) Drugs Market Size by Region, (2017-2022)
1.5.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size and Prospect (2017-2028)
1.5.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size and Prospect (2017-2028)
1.5.6 South America Peripheral Arterial Disease (PAD) Drugs Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Peripheral Arterial Disease (PAD) Drugs Market Drivers
1.6.2 Peripheral Arterial Disease (PAD) Drugs Market Restraints
1.6.3 Peripheral Arterial Disease (PAD) Drugs Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 AstraZeneca (UK)
2.1.1 AstraZeneca (UK) Details
2.1.2 AstraZeneca (UK) Major Business
2.1.3 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.1.4 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AstraZeneca (UK) Recent Developments and Future Plans
2.2 Bayer HealthCare Pharmaceuticals (Germany)
2.2.1 Bayer HealthCare Pharmaceuticals (Germany) Details
2.2.2 Bayer HealthCare Pharmaceuticals (Germany) Major Business
2.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.2.4 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments and Future Plans
2.3 Bristol-Myers Squibb Company (US)
2.3.1 Bristol-Myers Squibb Company (US) Details
2.3.2 Bristol-Myers Squibb Company (US) Major Business
2.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bristol-Myers Squibb Company (US) Recent Developments and Future Plans
2.4 Merck & Co (US)
2.4.1 Merck & Co (US) Details
2.4.2 Merck & Co (US) Major Business
2.4.3 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.4.4 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck & Co (US) Recent Developments and Future Plans
2.5 Proteon Therapeutics (US)
2.5.1 Proteon Therapeutics (US) Details
2.5.2 Proteon Therapeutics (US) Major Business
2.5.3 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.5.4 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Proteon Therapeutics (US) Recent Developments and Future Plans
2.6 Sanofi (France)
2.6.1 Sanofi (France) Details
2.6.2 Sanofi (France) Major Business
2.6.3 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.6.4 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Sanofi (France) Recent Developments and Future Plans
2.7 Symic Bio (US)
2.7.1 Symic Bio (US) Details
2.7.2 Symic Bio (US) Major Business
2.7.3 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.7.4 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Symic Bio (US) Recent Developments and Future Plans
2.8 TheraVasc (US)
2.8.1 TheraVasc (US) Details
2.8.2 TheraVasc (US) Major Business
2.8.3 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
2.8.4 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 TheraVasc (US) Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Peripheral Arterial Disease (PAD) Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Peripheral Arterial Disease (PAD) Drugs Players Market Share in 2021
3.2.2 Top 10 Peripheral Arterial Disease (PAD) Drugs Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Peripheral Arterial Disease (PAD) Drugs Players Head Office, Products and Services Provided
3.4 Peripheral Arterial Disease (PAD) Drugs Mergers & Acquisitions
3.5 Peripheral Arterial Disease (PAD) Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Peripheral Arterial Disease (PAD) Drugs Revenue and Market Share by Type (2017-2022)
4.2 Global Peripheral Arterial Disease (PAD) Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application (2017-2022)
5.2 Global Peripheral Arterial Disease (PAD) Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2028)
6.2 North America Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2028)
6.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
6.3.1 North America Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2028)
6.3.2 United States Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
6.3.3 Canada Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
6.3.4 Mexico Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2028)
7.2 Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2028)
7.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country
7.3.1 Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2028)
7.3.2 Germany Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
7.3.3 France Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
7.3.5 Russia Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
7.3.6 Italy Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2028)
8.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2028)
8.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region
8.3.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Region (2017-2028)
8.3.2 China Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
8.3.3 Japan Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
8.3.4 South Korea Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
8.3.5 India Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
8.3.7 Australia Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2028)
9.2 South America Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2028)
9.3 South America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
9.3.1 South America Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2028)
9.3.2 Brazil Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
9.3.3 Argentina Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2028)
10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2028)
10.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country
10.3.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2028)
10.3.2 Turkey Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
10.3.4 UAE Peripheral Arterial Disease (PAD) Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Peripheral Arterial Disease (PAD) Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) by Region (2017-2022)
Table 5. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Region (2023-2028)
Table 6. AstraZeneca (UK) Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca (UK) Major Business
Table 8. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 9. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bayer HealthCare Pharmaceuticals (Germany) Corporate Information, Head Office, and Major Competitors
Table 11. Bayer HealthCare Pharmaceuticals (Germany) Major Business
Table 12. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 13. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bristol-Myers Squibb Company (US) Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myers Squibb Company (US) Major Business
Table 16. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 17. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck & Co (US) Corporate Information, Head Office, and Major Competitors
Table 19. Merck & Co (US) Major Business
Table 20. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 21. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Proteon Therapeutics (US) Corporate Information, Head Office, and Major Competitors
Table 23. Proteon Therapeutics (US) Major Business
Table 24. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 25. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Sanofi (France) Corporate Information, Head Office, and Major Competitors
Table 27. Sanofi (France) Major Business
Table 28. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 29. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Symic Bio (US) Corporate Information, Head Office, and Major Competitors
Table 31. Symic Bio (US) Major Business
Table 32. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 33. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. TheraVasc (US) Corporate Information, Head Office, and Major Competitors
Table 35. TheraVasc (US) Major Business
Table 36. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Product and Solutions
Table 37. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Peripheral Arterial Disease (PAD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Peripheral Arterial Disease (PAD) Drugs Players Head Office, Products and Services Provided
Table 42. Peripheral Arterial Disease (PAD) Drugs Mergers & Acquisitions in the Past Five Years
Table 43. Peripheral Arterial Disease (PAD) Drugs New Entrants and Expansion Plans
Table 44. Global Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) by Type (2017-2022)
Table 45. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Type (2017-2022)
Table 46. Global Peripheral Arterial Disease (PAD) Drugs Revenue Forecast by Type (2023-2028)
Table 47. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2022)
Table 48. Global Peripheral Arterial Disease (PAD) Drugs Revenue Forecast by Application (2023-2028)
Table 49. North America Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 50. North America Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 51. North America Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 56. Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 57. Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 62. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 63. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 68. South America Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 69. South America Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2017-2022) & (USD Million)
Table 74. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Type (2023-2028) & (USD Million)
Table 75. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Peripheral Arterial Disease (PAD) Drugs Picture
Figure 2. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type in 2021
Figure 3. Clopidogrel (Plavix)
Figure 4. Prasugrel (Effient)
Figure 5. Ticagrelor (Brilinta)
Figure 6. Vorapaxar (Zontivity)
Figure 7. Others
Figure 8. Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application in 2021
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Peripheral Arterial Disease (PAD) Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Peripheral Arterial Disease (PAD) Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Region (2017-2028)
Figure 15. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Region in 2021
Figure 16. North America Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Peripheral Arterial Disease (PAD) Drugs Market Drivers
Figure 22. Peripheral Arterial Disease (PAD) Drugs Market Restraints
Figure 23. Peripheral Arterial Disease (PAD) Drugs Market Trends
Figure 24. AstraZeneca (UK) Recent Developments and Future Plans
Figure 25. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments and Future Plans
Figure 26. Bristol-Myers Squibb Company (US) Recent Developments and Future Plans
Figure 27. Merck & Co (US) Recent Developments and Future Plans
Figure 28. Proteon Therapeutics (US) Recent Developments and Future Plans
Figure 29. Sanofi (France) Recent Developments and Future Plans
Figure 30. Symic Bio (US) Recent Developments and Future Plans
Figure 31. TheraVasc (US) Recent Developments and Future Plans
Figure 32. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Players in 2021
Figure 33. Peripheral Arterial Disease (PAD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Peripheral Arterial Disease (PAD) Drugs Revenue Market Share in 2021
Figure 35. Global Top 10 Players Peripheral Arterial Disease (PAD) Drugs Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Type in 2021
Figure 38. Global Peripheral Arterial Disease (PAD) Drugs Market Share Forecast by Type (2023-2028)
Figure 39. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Application in 2021
Figure 40. Global Peripheral Arterial Disease (PAD) Drugs Market Share Forecast by Application (2023-2028)
Figure 41. North America Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Type (2017-2028)
Figure 42. North America Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Application (2017-2028)
Figure 43. North America Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Country (2017-2028)
Figure 50. Germany Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Peripheral Arterial Disease (PAD) Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
